2024 Emerging In Vitro Diagnostics Market: Strategic Implications of Market, Technological and Reimbursement Trends
- How will the future reimbursement changes affect individual market segments?
The report is available by section, and can be customized to specific information needs and budget.
- Will the industry consolidate, decentralize, or undergo a bimodal transformation?
- What will be the impact on purchasing influences, marketing strategies, joint ventures, mergers, licensing, import and export?
- How will the future technological advances affect the major market segments?
- Which companies will enter the market and which will not survive?
These and other key strategic issues facing decision-makers are explored in this thought-provoking and multi-faceted portrait of the future U.S. in vitro diagnostics market.
This invaluable strategic planning resource is designed to help corporate, marketing and R&D executives develop effective business plans that best accommodate uncertainties ahead. The report evaluates emerging markets and technologies that may present unexpected threats or offer opportunities; identifies key strategic decisions that will have to be made in the future; and enhances corporate ability to develop realistic contingency plans.
The report presents strategic overview of the U.S. in vitro diagnostics market, including major regulatory, economic, demographic and social trends with potentially significant impact; as well as five- and ten-year test volume and sales forecasts for major testing locations (hospitals, commercial labs, physician offices, blood centers, POC sites, and others) and laboratory disciplines (blood banking, clinical chemistry, immunodiagnostics, coagulation, hematology, flow cytometry, histology, cytology, microbiology, serology, urinalysis and others).
I. Executive Summary
2. Conclusions and Recommendations
3. Business Environment
a. Health Care Expenditures
b. Cost-Consciousness
c. Reimbursement
d. Industry Consolidation
e. Hospitals
f. Admissions
g. Length of Stay
h. Industry Diversification
i. Physician Demographics
j. Aging Population
- More Chronic Illnesses
- Higher Incidence of Disease
- Greater Susceptibility to Iatrogenesis
- More Cases with Multiple Illnesses
4. Outlook for the In Vitro Diagnostics Market
a. Government Regulations
b. FDA Reform
c. Hospitals
d. Commercial Laboratories
e. Physician Offices
f. Point-of-Care Testing
g. Personal Testing
h. Other Testing Locations
5. Strategic Implications
a. Testing Patterns
- Test Utilization
- Pre-Admission Testing
- Inpatient Testing
- Outpatient Testing
6. Market Segments
a. Clinical Chemistry and Immunodiagnostics
- Introduction
- Future Situation
b. Microbiology and Serology
- Introduction
- Future Situation
c. Hematology and Flow Cytometry
- Introduction
- Future Situation
d. Blood Banking
- Introduction
- Future Situation
e. Histology and Cytology
- Introduction
- Future Situation
f. Coagulation
- Introduction
- Future Situation
g. Urinalysis
- Introduction
- Future Situation
7. Technologies
a. Molecular Diagnostics
- Introduction
- Future Situation
b. Monoclonal Antibodies
- Introduction
- Future Situation
c. Solid Phase Chemistry
- Introduction
- Future Situation
d. Biosensors and Biochips
- Introduction
- Future Situation
e. Automation and Robotics
- Introduction
- Future Situation
f. IT
- Introduction
- Future Situation
8. The New Marketplace
a. Purchasing Influences
b. Marketing Strategies
c. Joint Venture, Merger, and Licensing Activity
d. Import-Export
e. Potential Market Entrants
f. Who May Not Survive?
List Of Tables
Executive Summary Table: Growth Areas in Clinical Laboratory Testing
Table-1: Estimated U.S. Health Care Expenditures By Type
Table-2: Health Plan Enrollment Distribution
Table-3: Selected Hospital Statistics
Table-4: Total Population And Physician Demographics
Table-5: Test Volume By Location
Table-6: Test Distribution By Location
Table-7: Market Size By Location
Table-8: Typical Pre-Admission Tests
Table-9: Test Volume By Laboratory Discipline
Table-10: Market Size By Laboratory Discipline
2024 Italy Hospital Tumor Marker Testing Market Supplier Shares by Test and Strategies Volume and Sales Segment Forecasts Technology and Instrumentation Review Emerging Opportunities
2024 Italy Hospital Tumor Marker Testing Market: Supplier Shares by Test and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review, Emerging Opportunities This new report from contains 525
USD 3450 View Report2024 Germany Hospital Tumor Marker Testing Market Supplier Shares by Test and Strategies Volume and Sales Segment Forecasts Technology and Instrumentation Review Emerging Opportunities
2024 Germany Hospital Tumor Marker Testing Market: Supplier Shares by Test and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review, Emerging Opportunities This new report from contains 530
USD 3450 View Report2024 Emerging US Diagnostic Testing Market Supplier Shares by Test and Segment Sales Forecasts
2024 Emerging US Diagnostic Testing Market: Supplier Shares by Test and Segment Sales ForecastsThis new report from provides an overview of the US diagnostic testing market.The report is available by
USD 3750 View Report2024 Emerging UK Diagnostic Testing Market Supplier Shares by Test and Segment Sales Forecasts
2024 Emerging UK Diagnostic Testing Market: Supplier Shares by Test and Segment Sales Forecasts This new report from provides an overview of the UK diagnostic testing market.The report is available
USD 3750 View ReportFill The Form For Sample Request